Does Pfizer Inc. Stock Offer a Market-Crushing Opportunity in 2015?
Pfizer's stock has languished for the better part of a decade now, failing to benefit from the broader bull market. With several key events on the horizon, this trend could change in a big way. Here's what investors need to know.
Does This Dividend Stock Belong in Your Portfolio in 2015?
Teva Pharmaceutical Industries is a favorite name among income investors. With steep headwinds facing the company in 2015, though, its dividend might be at risk. Here's what investors need to know.